Rallybio Corp 8-K Summary: Annual Meeting Results
Business Context and Reporting Period
Rallybio Corporation (RLYB), an emerging growth company incorporated in Delaware, filed this Form 8-K on May 16, 2025, to report the results of its annual meeting of shareholders held on May 13, 2025.
Key Financial Metrics
This filing is a Current Report regarding corporate governance events and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data.
Material Changes
The filing reports the outcome of shareholder votes on director elections and auditor ratification. No material changes to financial operations or business strategy are disclosed in this document.
Management Commentary and Governance Outcomes
- Director Elections: Shareholders elected Martin W. Mackay and Paula Soteropoulos as Class I directors for terms expiring in 2028. Both nominees received significant "Against" votes (approximately 3.1 million each) alongside "For" votes of approximately 23.8 million each.
- Auditor Ratification: Shareholders ratified the appointment of Deloitte and Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, with overwhelming support (34.6 million "For" votes versus 40,810 "Against" votes).
Investor Verification Checklist
- Verify the total number of shares outstanding to contextualize the "Against" vote percentages for the director elections.
- Review the company's proxy statement for the 2025 annual meeting to understand the rationale behind the significant dissenting votes for the director nominees.
- Confirm the company's cash runway and burn rate in the most recent 10-Q or 10-K, as this 8-K contains no financial data.